Latest Breaking News On - அளவு மருந்து - Page 3 : comparemela.com
Predictive Oncology Reports Year End 2020 Financial Results, Provides Business Update
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Breaking News: MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company | Breaking News: MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine CompanyFinancial Buzz
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company
News provided by
Share this article
Share this article
Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Karlin M.D. M.A. and former Google AI/ML industry veteran Bradford Cross added to MindMed executive team
NEW YORK, Feb. 18, 2021 /PRNewswire/
MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company, announced that it will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
+1.29%Price Rebound Comparing Fridayâs (1/22) Low To Close
As youâll see, Fridayâs action was very different in biotech stocks compared to broader sector stocks. The IBB outperformed both the Nasdaq QQQ and S&P 500 SPY by a wide margin. Something else to note is that it did so even with much lighter volume than the ETF had seen in previous trading sessions. If you look at how many shares traded on January 19th, compared to the 22nd, the ETFs 1.29% rebound came with far less market action. How much less?
On Monday, the IBB traded 4.84 million shares and moved up 1.29% from its low to its closing price. Friday, the IBB only traded 1.37 million shares but recorded that 1.29% rebound in price. Considering that it was lower volume during the 3-day consolidation in the IBB, could this be a sign of a new reversal trend? Weâll have to see how things fair this week. Top Biotech Penny Stocks To Buy [or avoid]
+1.29%Price Rebound Comparing Fridayâs (1/22) Low To Close
As youâll see, Fridayâs action was very different in biotech stocks compared to broader sector stocks. The IBB outperformed both the Nasdaq QQQ and S&P 500 SPY by a wide margin. Something else to note is that it did so even with much lighter volume than the ETF had seen in previous trading sessions. If you look at how many shares traded on January 19th, compared to the 22nd, the ETFs 1.29% rebound came with far less market action. How much less?
On Monday, the IBB traded 4.84 million shares and moved up 1.29% from its low to its closing price. Friday, the IBB only traded 1.37 million shares but recorded that 1.29% rebound in price. Considering that it was lower volume during the 3-day consolidation in the IBB, could this be a sign of a new reversal trend? Weâll have to see how things fair this week. Top Biotech Penny Stocks To Buy [or avoid]
vimarsana © 2020. All Rights Reserved.